Clinical Trial Update: A Phase 2/3 Study in Adult and Adolescent Participants With SCD [Phase 2, Phase 3]

View source ↗

Summary

Pfizer is conducting a Phase 2/3 clinical trial in adults and adolescents with Sickle Cell Disease, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: Pfizer | Conditions: Sickle Cell Disease | Phase 2, Phase 3 | Status: RECRUITING